<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:georss="http://www.georss.org/georss" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:media="http://search.yahoo.com/mrss/"
		>
<channel>
	<title>Comments on: Notes from the 12th Annual National Institute on Class Actions</title>
	<atom:link href="http://classactionblawg.com/2008/11/08/notes-from-the-12th-annual-national-institute-on-class-actions/feed/" rel="self" type="application/rss+xml" />
	<link>http://classactionblawg.com/2008/11/08/notes-from-the-12th-annual-national-institute-on-class-actions/</link>
	<description>class action news, commentary, and analysis</description>
	<lastBuildDate>Fri, 10 Feb 2012 23:19:52 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.com/</generator>
	<item>
		<title>By: New CADS Report Highlights International Class Action Litigation Trends &#171; ClassActionBlawg.com</title>
		<link>http://classactionblawg.com/2008/11/08/notes-from-the-12th-annual-national-institute-on-class-actions/#comment-764</link>
		<dc:creator><![CDATA[New CADS Report Highlights International Class Action Litigation Trends &#171; ClassActionBlawg.com]]></dc:creator>
		<pubDate>Wed, 11 Feb 2009 07:02:32 +0000</pubDate>
		<guid isPermaLink="false">http://classactionblawg.wordpress.com/?p=667#comment-764</guid>
		<description><![CDATA[[...] an article authored by three Canadian panelists from a presentation of the same name from November&#8217;s ABA National Institute on Class Actions, David I.W. Hamer, Sylvie Rodrique, and Charles M. Wright.  The article outlines recent trends in [...]]]></description>
		<content:encoded><![CDATA[<p>[...] an article authored by three Canadian panelists from a presentation of the same name from November&#8217;s ABA National Institute on Class Actions, David I.W. Hamer, Sylvie Rodrique, and Charles M. Wright.  The article outlines recent trends in [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: With Vigour and Zeal &#187; Blog Archive &#187; Wrapping it up, 26 November 2008</title>
		<link>http://classactionblawg.com/2008/11/08/notes-from-the-12th-annual-national-institute-on-class-actions/#comment-574</link>
		<dc:creator><![CDATA[With Vigour and Zeal &#187; Blog Archive &#187; Wrapping it up, 26 November 2008]]></dc:creator>
		<pubDate>Wed, 26 Nov 2008 12:08:30 +0000</pubDate>
		<guid isPermaLink="false">http://classactionblawg.wordpress.com/?p=667#comment-574</guid>
		<description><![CDATA[[...] has published notes on the 12th Annual National Institute on Class Actions conference (previous post), including on the [...]]]></description>
		<content:encoded><![CDATA[<p>[...] has published notes on the 12th Annual National Institute on Class Actions conference (previous post), including on the [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Class Action Blogosphere Weekly Review &#171; ClassActionBlawg.com</title>
		<link>http://classactionblawg.com/2008/11/08/notes-from-the-12th-annual-national-institute-on-class-actions/#comment-519</link>
		<dc:creator><![CDATA[Class Action Blogosphere Weekly Review &#171; ClassActionBlawg.com]]></dc:creator>
		<pubDate>Thu, 13 Nov 2008 06:14:50 +0000</pubDate>
		<guid isPermaLink="false">http://classactionblawg.wordpress.com/?p=667#comment-519</guid>
		<description><![CDATA[[...] FiercePharma and Pharmalot discuss a Florida federal court&#8217;s decision dismissing a RICO case filed against a drug manufacturer for alleged fraud in its marketing practices about the safety and effectiveness of its product, a decision that appears to conflict with Judge Weinstein&#8217;s recent Zyprexa decision (discussed at the recent National Institute on Class Actions): [...]]]></description>
		<content:encoded><![CDATA[<p>[...] FiercePharma and Pharmalot discuss a Florida federal court&#8217;s decision dismissing a RICO case filed against a drug manufacturer for alleged fraud in its marketing practices about the safety and effectiveness of its product, a decision that appears to conflict with Judge Weinstein&#8217;s recent Zyprexa decision (discussed at the recent National Institute on Class Actions): [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

